Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2011 1
2015 1
2016 7
2017 6
2018 2
2019 3
2020 6
2023 1
2024 11
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
[Alpha 1-antitrypsin deficiency].
Fähndrich S, Bals R. Fähndrich S, et al. Inn Med (Heidelb). 2024 Jun;65(6):533-537. doi: 10.1007/s00108-024-01722-2. Epub 2024 May 24. Inn Med (Heidelb). 2024. PMID: 38789803 Review. German.
Impact of elexacaftor/tezacaftor/ivacaftor on lung function, nutritional status, pulmonary exacerbation frequency and sweat chloride in people with cystic fibrosis: real-world evidence from the German CF Registry.
Sutharsan S, Dillenhoefer S, Welsner M, Stehling F, Brinkmann F, Burkhart M, Ellemunter H, Dittrich AM, Smaczny C, Eickmeier O, Kappler M, Schwarz C, Sieber S, Naehrig S, Naehrlich L; German CF Registry of the Mukoviszidose e.V. and participating CF sites. Sutharsan S, et al. Lancet Reg Health Eur. 2023 Jul 28;32:100690. doi: 10.1016/j.lanepe.2023.100690. eCollection 2023 Sep. Lancet Reg Health Eur. 2023. PMID: 37554663 Free PMC article.
Alpha-1-antitrypsin-deficiency is associated with lower cardiovascular risk: an approach based on federated learning.
Zöller D, Haverkamp C, Makoudjou A, Sofack G, Kiefer S, Gebele D, Pfaffenlehner M, Boeker M, Binder H, Karki K, Seidemann C, Schmeck B, Greulich T, Renz H, Schild S, Seuchter SA, Tibyampansha D, Buhl R, Rohde G, Trudzinski FC, Bals R, Janciauskiene S, Stolz D, Fähndrich S. Zöller D, et al. Among authors: fahndrich s. Respir Res. 2024 Jan 18;25(1):38. doi: 10.1186/s12931-023-02607-y. Respir Res. 2024. PMID: 38238846 Free PMC article.
[Alpha-1-antitrypsin deficiency - an update].
Bernhard N, Bals R, Fähndrich S. Bernhard N, et al. Among authors: fahndrich s. Dtsch Med Wochenschr. 2016 Sep;141(20):1467-1469. doi: 10.1055/s-0042-112096. Epub 2016 Oct 4. Dtsch Med Wochenschr. 2016. PMID: 27701692 Review. German.
Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort.
Frantzi N, Nguyen XP, Herr C, Alter P, Söhler S, Soriano D, Watz H, Waschki B, Trinkmann F, Eichenlaub M, Trudzinski FC, Michels-Zetsche JD, Omlor A, Seiler F, Moneke I, Biertz F, Rohde G, Stolz D, Welte T, Kauczor HU, Kahnert K, Jörres RA, Vogelmeier CF, Bals R, Fähndrich S; German COSYCONET Cohort. Frantzi N, et al. Among authors: fahndrich s. Respir Res. 2024 May 15;25(1):207. doi: 10.1186/s12931-024-02822-1. Respir Res. 2024. PMID: 38750572 Free PMC article.
Midregional Proatrial Natriuretic Peptide (MRproANP) is associated with vertebral fractures and low bone density in patients with chronic obstructive pulmonary disease (COPD).
Trudzinski FC, Jörres RA, Alter P, Watz H, Vogelmeier CF, Kauczor HU, Thangamani S, Debic M, Welte T, Behr J, Kahnert K, Bals R, Herr C, Heußel CP, Biederer J, von Stackelberg O, Fähndrich S, Wouters EFM, Waschki B, Rabe KF, Herth FJF, Palm V; COSYCONET study group. Trudzinski FC, et al. Among authors: fahndrich s. Respir Res. 2024 Jul 13;25(1):274. doi: 10.1186/s12931-024-02902-2. Respir Res. 2024. PMID: 39003487 Free PMC article.
Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD-results from COSYCONET.
Fähndrich S, Herr C, Teuteberg S, Alter P, Söhler S, Soriano D, Classen J, Adams J, Weinhold V, Watz H, Waschki B, Zeller T, Eichenlaub M, Trudzinski FC, Michels JD, Omlor A, Seiler F, Moneke I, Biertz F, Stolz D, Welte T, Kauczor HU, Kahnert K, Jörres RA, Vogelmeier CF, Bals R; German COSYCONET Cohort. Fähndrich S, et al. Respir Res. 2024 Jan 24;25(1):56. doi: 10.1186/s12931-024-02690-9. Respir Res. 2024. PMID: 38267944 Free PMC article.
Cardiovascular risk in patients with alpha-1-antitrypsin deficiency.
Fähndrich S, Biertz F, Karch A, Kleibrink B, Koch A, Teschler H, Welte T, Kauczor HU, Janciauskiene S, Jörres RA, Greulich T, Vogelmeier CF, Bals R; COSYCONET investigators. Fähndrich S, et al. Respir Res. 2017 Sep 15;18(1):171. doi: 10.1186/s12931-017-0655-1. Respir Res. 2017. PMID: 28915894 Free PMC article.
Eosinopenia as Predictor of Disease Severity in Patients With Community-Acquired Pneumonia: An Observational Study.
Weckler BC, Pott H, Race A, Jugkaeo N, Karki K, Ringshandl S, Seidemann C, Schöndorf I, Renz H, Fähndrich S, Jung AL, Bertrams W, Makoudjou A, Zöller D, Finotto S, Schild S, Seuchter SA, Rohde G, Trinkmann F, Greulich T, Vogelmeier CF, Schmeck B. Weckler BC, et al. Among authors: fahndrich s. Chest. 2024 Dec;166(6):1329-1333. doi: 10.1016/j.chest.2024.05.041. Epub 2024 Jul 5. Chest. 2024. PMID: 38972349 Free PMC article. No abstract available.
[Alpha-1 Antitrypsin Deficiency (AATD) - D-A-CH-Expert Statement].
Greulich T, Fähndrich S, Clarenbach C, Gleiber W, Hautmann H, Heine R, Idzko M, Schmidt-Scherzer K, Skowasch D, Wiewrodt R, Bals R, Koczulla AR. Greulich T, et al. Among authors: fahndrich s. Pneumologie. 2020 Jul;74(7):436-442. doi: 10.1055/a-1143-8186. Epub 2020 Jun 3. Pneumologie. 2020. PMID: 32492720 Free article. German. No abstract available.
39 results